NOCITA is an amide local anesthetic in an encapsulated liposomal formulation that was developed with the goal of providing a longer duration of post-operative analgesia compared with its nonliposomal counterpart bupivacaine HCl or other local anesthetics. The use of NOCITA contributes to a modern multi-modal analgesia plan. Its extended duration of action assists in preventing analgesia gaps during the first 72 hours following CCL surgery in dogs and provides a bridge between an in-hospital analgesia plan and a strategy instituted in the home environment. Additionally, NOCITA is administered at the time of closure by the surgeon and does not require repeat or continuous administration post-operatively, saving valuable technician time.
Please see full Prescribing Information for more detail.
Video was produced in 2016 while Dr. Rausch-Derra served as Vice President of Regulatory Affairs for Aratana.